Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer

Herbst RS, MorgenszternC D. Boshoff The biology and management of non-small cell lung cancer. Nature. 2018;553:446–54.

Article  CAS  PubMed  Google Scholar 

Akanda ZZ, Neeson PJ, John T, Barnett S, Hanna GG, et al. A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer. Transl Lung Cancer Res. 2021;10:2766–78.

Article  CAS  PubMed  Google Scholar 

Davies AM, Lara PN Jr., Mack PC, Gandara DR. Docetaxel in non-small cell lung cancer: a review. Expert Opin Pharmacother. 2003;4:553–65.

de Weger VA, Beijnen JH, Schellens JH. Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel-a review. Anticancer Drugs. 2014;25:488–94.

Lemjabbar-Alaoui H, Hassan OU, YangP YW. Buchanan Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856:189–210.

CAS  PubMed  PubMed Central  Google Scholar 

ten Tije AJ, Verweij J, LoosA WJ. Sparreboom Pharmacological effects of formulation vehicles : implications for cancer chemotherapy. Clin Pharmacokinet. 2003;42:665–85.

Article  PubMed  Google Scholar 

Bissery MC. Preclinical pharmacology of docetaxel. Eur J Cancer. 1995;31A(Suppl 4):S1-6.

Article  CAS  Google Scholar 

Kratz F. A clinical update of using albumin as a drug vehicle - a commentary. J Control Release. 2014;190:331–6.

Article  CAS  PubMed  Google Scholar 

Desai N, Trieu V, Yao Z, Louie L, Ci S, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006;12:1317–24.

Article  CAS  PubMed  Google Scholar 

Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75:544–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yardley DA. nab-Paclitaxel mechanisms of action and delivery. J Control Release. 2013;170:365–72.

Article  CAS  PubMed  Google Scholar 

Kushwah V, Katiyar SS, Dora CP, Kumar Agrawal A, Lamprou AA, et al. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management. Acta Biomater. 2018;73:424–36.

Kordezangeneh M, Irani S, Mirfakhraie R, Esfandyari-Manesh M, Atyabi F, et al. Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles. Med Oncol. 2015;32:208.

Article  PubMed  Google Scholar 

Li CL, Li YH, Gao YQ, Wei N, Zhao X, et al. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Int J Pharmaceut. 2014;468:15–25.

Article  CAS  Google Scholar 

Sato T, Okazaki M, Sano J, Kato C, Shimizu K, et al. Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin-bound paclitaxel-derived albumin from human serum. Biomed Rep. 2021;14:35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33:209–90.

Article  CAS  PubMed  Google Scholar 

Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, et al. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends. Int J Nanomed. 2018;13:3145–61.

Article  CAS  Google Scholar 

Cheng HX, Liu H, Zhang YY, Zou GL. Interaction of the docetaxel with human serum albumin using optical spectroscopy methods. J Lumin. 2009;129:1196–203.

Elsadek BF. Kratz Impact of albumin on drug delivery - new applications on the horizon. J Control Release. 2012;157:4–28.

Article  CAS  PubMed  Google Scholar 

Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132:171–83.

Article  CAS  PubMed  Google Scholar 

Clarke SJLP. Rivory Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet. 1999;36:99–114.

Article  CAS  PubMed  Google Scholar 

Torzilli PA, Bourne JW, Cigler T, Vincent CT. A new paradigm for mechanobiological mechanisms in tumor metastasis. Semin Cancer Biol. 2012;22:385–95.

Park K. Albumin: a versatile carrier for drug delivery. J Control Release. 2012;157:3–3.

Article  CAS  PubMed  Google Scholar 

Kellar A, EganD C. Morris Preclinical murine models for lung cancer: clinical trial applications. Biomed Res Int. 2015;2015: 621324.

Article  PubMed  PubMed Central  Google Scholar 

Wood SL, Pernemalm M, Crosbie PA, Whetton AD. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat Rev. 2014;40:558–66.

Mazzaccara C, Labruna G, Cito G, Scarfo M, De Felice M, et al. Age-related reference intervals of the main biochemical and hematological parameters in C57BL/6J, 129SV/EV and C3H/HeJ mouse strains. PLoS ONE. 2008;3: e3772.

Article  PubMed  PubMed Central  Google Scholar 

Hu K, Miao L, Goodwin TJ, Li J, Liu Q, et al. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano. 2017;11:4916–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif